Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
|Active Ingredient:||Haemophilus influenzae type b vaccine 10mcg|
|Dosage Form:||Powder for injection with diluent|
|New Zealand Sponsor:||Sanofi-Aventis New Zealand Limited|
|Manufacturers:||Sanofi Pasteur SA, Marcy L’Etoile, France
Sanofi SpA, Frosinone, Italy
Sanofi Pasteur SA, Val-De-Reuil, France
|Active Ingredient:||Simeticone 100mg|
|Dosage Form:||Liquid filled capsule|
|New Zealand Sponsor:||GlaxoSmithKline Consumer Healthcare New Zealand ULC|
|Manufacturers:||Catalent Australia Pty Limited, Melbourne, Australia
Catalent Ontario Limited, Windsor, Canada
Dated this 8th day of June 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).